Serogroup B meningococcal vaccination practice patterns on college campuses. Issue 46 (27th October 2020)

• Record Type: Journal Article
• Authors: Haimowitz, Rachel; Torres, Rachel; Caleb, Susan; Thompson, Danielle; Smith, Allison; Ciotoli, Carlo; Dannenbaum, Martha; Fu, Linda Y.
• Is Part Of: Vaccine. Volume 38:Issue 46(2020)
• Page Start: 7350
• Page End: 7356
• Publication Date: 2020-10-27
• Subjects: Vaccination -- Meningococcal vaccines -- Practice guidelines -- Young adult -- Quality improvement -- College; ACHA American College Health Association -- ACIP Advisory Committee on Immunization Practices -- HCP healthcare provider -- IPEDS Integrated Postsecondary Education Data System -- MenACWY meningococcal A, C, W, Y conjugate vaccine -- MenB meningococcal serogroup B vaccine -- SHC Student Health Center; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2020.09.035
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: Background: Most Neisseria meningitidis involved in invasive disease among American college students express serogroup B antigen. The Advisory Committee on Immunization Practices (ACIP) recommends healthcare providers (HCPs) share clinical decision making with patients to determine individual value of meningococcal serogroup B vaccination (MenB) rather than routinely recommend vaccination as with the meningococcal A, C, W, Y vaccine (MenACWY). This study examines the attitudes and practices of HCPs working in college student health centers (SHCs) regarding the recommendation and administration of MenB to students. Methods: The study was conducted as an online and phone survey of SHC HCPs from a sample of colleges across the United States between May 2017 and July 2018. Items compared college SHC policies and practices for MenB to those for MenACWY. It also assessed perceived barriers to and facilitators of MenB delivery to students. Results: Among the 147 respondents, almost 50% more reported their SHC stocked and administered MenACWY (54.1%) than MenB (37%) ( p = .004). Almost five times as many colleges required their students receive MenACWY as MenB (53.5% vs. 10.5%, p < .001). A greater percentage requested students to submit records for MenACWY than MenB (77.3% vs. 46.9%, p < .001), and over three times as many tracked student-body coverage rates for MenACWY than MenB (55.6% vs. 15.8%, p < .001). Nearly three quarters of respondents estimated their college's student body MenB coverage rate to be ≤ 10% or were unable to provide any estimate. Factors perceived by over half of the participants as moderate to extreme barriers to administering MenB included high upfront costs for SHCs to purchase and stock MenB (68.7%), and high out-of-pocket costs for students to receive it (82.8%). Conclusions: A minority of college SHCs require, offer or track Men B vaccination on their campuses. Financial concerns are common barriers to SHCs' stocking and administering MenB to students.